Project Grant HT94252510771
Award Date
9/15/25
Completion Date
9/14/27
Dollars Obligated
$250K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Buffalo, NY 14228, USA
Similar Awards
The U.S. Defense Health Agency awarded a $320,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Regents of the University of Michigan. The grant, titled "IMPACT OF THE INTEGRATED STRESS RESPONSE ON VISUAL SYNAPTIC CIRCUITS IN MULTIPLE SCLEROSIS", will support advanced biomedical research focused on transforming healthcare for military service members, veterans, and the broader public. The research, to be conducted from September 1,...
This $998,436 Project Grant was awarded on July 1, 2023 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Research Foundation for the State University of New York (RF SUNY) to study the molecular mechanisms and therapeutic potential of heparan sulfate proteoglycans in remyelination. This 3-year research project aims to transform health care for Service Members and the American public through innovative and...
This federal Project Grant award of $673,448.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The award was granted to The Research Foundation For The State University Of New York (RF SUNY) to conduct research on the "MALADAPTIVE 5-HT RAPHE-CORTICOLIMBIC PLASTICITY UNDERLYING THE...
This federal Project Grant award of $249,999.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is supporting research conducted by the University of Maryland, Baltimore (UMB) to gain insights into multiple sclerosis pathology. The research project will leverage 7-T MRI and multiomics analysis of serologic samples to advance the understanding of this neurological disorder. The award period runs from August 15, 2024 to August 14,...
The federal Project Grant award of $249,612.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award is funding research by Yale University to unravel the causal impact of multiple sclerosis (MS)-associated genetic variants on T cell immune tolerance. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing the understanding of MS pathogenesis through...
The U.S. Department of Defense's Defense Health Agency awarded a $319,204 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) to conduct research on "Advanced Brain Age Modeling in Multiple Sclerosis: Toward a Prognostic Biomarker for Personalized Medicine." The award, which runs from August 15, 2024, to August 14, 2026, is part of the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research initiatives aimed at...
This $240,897 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support integrative transcriptomic and epigenomic profiling of subependymal giant cell astrocytoma at single-cell resolution. The award was made to Duke University's Office of Research Administration on August 1, 2025, with a period of performance through July 31, 2027. The Military Medical Research and Development program funds advanced biomedical...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,938,711 Project Grant to The Research Foundation for the State University of New York (RF-SUNY) on April 1, 2024. The grant will fund research to identify new biological and therapeutic targets for myotonic dystrophy type 1, a genetic disorder that causes progressive muscle weakness and wasting. The project aims to transform health care for service members and the public by conducting...
The federal Project Grant award of $200,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support research conducted by Northwestern University to elucidate the neural basis of hallucinations in Parkinson's disease. The award, effective July 1, 2025 through June 30, 2027, will enable Northwestern University's researchers to investigate this critical medical challenge and develop innovative solutions to transform healthcare for military...
The U.S. Department of Defense's Defense Health Agency has awarded a $1,179,730 Project Grant to The Research Foundation for the State University of New York (RF-SUNY) at the University at Albany. The grant, under the Military Medical Research and Development program (CFDA 12.420), will fund research to identify new biological and therapeutic targets for myotonic dystrophy type 1, a genetic disorder affecting muscle function. The four-year grant, which began on April 1, 2024, will support basic,...